Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.

Kalathiya UN, Yuang K, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG

Open source

DOI: 10.1016/j.eprac.2026.04.004
Published: 2026 Sep
Container: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eprac.2026.04.004,
  title = {Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.},
  author = {Kalathiya UN and Yuang K and Herrin J and Swarna KS and Deng Y and Polley EC and Neumiller JJ and Galindo RJ and Umpierrez GE and Ross JS and Brito JP and Montori VM and Borah BJ and Maron BA and Mickelson MM and McCoy RG},
  year = {2026},
  journal = {Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
  doi = {10.1016/j.eprac.2026.04.004},
  url = {https://doi.org/10.1016/j.eprac.2026.04.004}
}

RIS

TY  - JOUR
TI  - Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.
AU  - Kalathiya UN
AU  - Yuang K
AU  - Herrin J
AU  - Swarna KS
AU  - Deng Y
AU  - Polley EC
AU  - Neumiller JJ
AU  - Galindo RJ
AU  - Umpierrez GE
AU  - Ross JS
AU  - Brito JP
AU  - Montori VM
AU  - Borah BJ
AU  - Maron BA
AU  - Mickelson MM
AU  - McCoy RG
PY  - 2026
JO  - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
DO  - 10.1016/j.eprac.2026.04.004
UR  - https://doi.org/10.1016/j.eprac.2026.04.004
ER  -

APA

UN, K., K, Y., J, H., KS, S., Y, D., EC, P., JJ, N., RJ, G., GE, U., JS, R., JP, B., VM, M., BJ, B., BA, M., MM, M., & RG, M. (2026). Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. https://doi.org/10.1016/j.eprac.2026.04.004

Source records

pubmed · retrieved 2026-09-26T12:10:09.556Z